Moderate Established

Описание

Carbamazepine, a potent enzyme inducer, significantly reduces sertraline plasma concentrations, potentially impairing antidepressant efficacy.

Механизм

Carbamazepine induces CYP3A4 and CYP2C19, accelerating sertraline metabolism and lowering its AUC by up to 65%, reducing antidepressant effect.

Клиническое значение

Sertraline plasma levels may be reduced below therapeutic thresholds; loss of antidepressant efficacy and worsening depression risk.

Тактика ведения

Monitor antidepressant response closely; sertraline dose increases may be required, or an alternative not metabolized by CYP3A4 should be considered.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.